NYSE:INFU InfuSystem (INFU) Stock Price, News & Analysis $10.16 +0.14 (+1.40%) Closing price 07/2/2026 04:00 PM EasternExtended Trading$10.15 -0.01 (-0.10%) As of 07/2/2026 05:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsTrendsBuy This Stock About InfuSystem Stock (NYSE:INFU) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get InfuSystem alerts:Sign Up Key Stats Today's Range$9.94▼$10.2450-Day Range$8.21▼$10.6652-Week Range$5.38▼$11.04Volume81,457 shsAverage Volume171,930 shsMarket Capitalization$205.05 millionP/E Ratio169.36Dividend YieldN/APrice Target$15.00Consensus RatingModerate Buy Company Overview InfuSystem Holdings Inc is a medical technology company that specializes in the rental, management and servicing of infusion pumps and associated devices used primarily for outpatient infusion therapy. The company provides a comprehensive suite of services that includes equipment delivery, setup and retrieval, preventive and corrective maintenance, reprocessing and quality assurance. InfuSystem’s offerings are designed to help hospitals, ambulatory surgery centers, oncology clinics and private infusion suites streamline clinical operations and maintain compliance with safety standards. In addition to pump rental and repair services, InfuSystem has expanded into remote patient monitoring solutions. By integrating connected infusion pumps with data analytics and telehealth platforms, the company enables healthcare providers to monitor therapy progress, optimize patient outcomes and improve staff efficiency. This end-to-end model supports a broad range of IV infusion therapies, including chemotherapy, pain management and antibiotic administration. Headquartered in St. Petersburg, Florida, InfuSystem was founded in the late 1980s and has grown to serve healthcare facilities across the United States and select international markets. The company is governed by a board of directors and a management team with deep experience in medical device services and healthcare operations. InfuSystem continues to invest in technology and infrastructure to meet evolving regulatory requirements and the shifting landscape of outpatient care.AI Generated. May Contain Errors. Read More InfuSystem Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks85th Percentile Overall ScoreINFU MarketRank™: InfuSystem scored higher than 85% of companies evaluated by MarketBeat, and ranked 89th out of 855 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.3 / 5Analyst RatingModerate Buy Consensus RatingInfuSystem has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on no strong buy ratings, 2 buy ratings, 1 hold rating, and no sell ratings.Upside PotentialInfuSystem has a consensus price target of $15.00, representing about 47.6% upside from its current price of $10.16.Amount of Analyst CoverageInfuSystem has received no research coverage in the past 90 days.Read more about InfuSystem's stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth106.67% Earnings GrowthEarnings for InfuSystem are expected to grow by 106.67% in the coming year, from $0.15 to $0.31 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of InfuSystem is 169.36, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 46.21.Price to Earnings Ratio vs. SectorThe P/E ratio of InfuSystem is 169.36, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 27.92.Price to Book Value per Share RatioInfuSystem has a P/B Ratio of 4.11. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for INFU. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldInfuSystem does not currently pay a dividend.Dividend GrowthInfuSystem does not have a long track record of dividend growth. News and Social Media2.5 / 5News SentimentN/A News SentimentInfuSystem has a news sentiment score of 1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.84 average news sentiment score of Medical companies.Search InterestOnly 3 people have searched for INFU on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added InfuSystem to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Company Ownership4.7 / 5Insider TradingAcquiring Shares Cluster Insider Buying3 insiders have purchased shares of InfuSystem in the last three months. Multiple insiders buying is a strong bullish signal.Net Insider BuyingOver the last three months, insiders have purchased a net $131,490.00 in company stock, which represents 0.0641% of the company's market cap.Insider Buying vs. Insider SellingIn the past three months, InfuSystem insiders have bought more of their company's stock than they have sold. Specifically, they have bought $131,490.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders10.80% of the stock of InfuSystem is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions71.13% of the stock of InfuSystem is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about InfuSystem's insider trading history. Receive INFU Stock News and Ratings via Email Sign-up to receive the latest news and ratings for InfuSystem and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. INFU Stock News HeadlinesInfuSystem: A Good Time To Buy Before A Potential BreakoutJune 23, 2026 | seekingalpha.comInfuSystem announces $20M stock repurchase programMay 19, 2026 | seekingalpha.comThe $15 Gold Fund That Pays Up to $1,152/MonthGold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying out up to $1,152 a month to regular investors - no mining stocks, no options, no physical metal required. Chief Income Strategist Tim Plaehn calls it a breakthrough strategy that transforms gold's rally into reliable monthly payouts. The next distribution is just days away. | Investors Alley (Ad)InfuSystem Announces New $20 Million Share Repurchase ProgramMay 18, 2026 | tipranks.comInfuSystem Announces $20 Million Stock Repurchase ProgramMay 18, 2026 | businesswire.comInfuSystem Stockholders Approve Expanded Equity Plan and BoardMay 14, 2026 | theglobeandmail.comInfuSystem Appoints Beverly Huss as New Board ChairMay 14, 2026 | tipranks.comInfuSystem Holdings, Inc. (INFU) Shareholder/Analyst Call Prepared Remarks TranscriptMay 11, 2026 | seekingalpha.comSee More Headlines INFU Stock Analysis - Frequently Asked Questions How have INFU shares performed this year? InfuSystem's stock was trading at $8.97 at the beginning of 2026. Since then, INFU stock has increased by 13.3% and is now trading at $10.16. How were InfuSystem's earnings last quarter? InfuSystem Holdings, Inc. (NYSE:INFU) posted its quarterly earnings results on Thursday, November, 7th. The company reported $0.08 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.08. The firm earned $35.32 million during the quarter, compared to the consensus estimate of $35.50 million. InfuSystem had a net margin of 1.12% and a trailing twelve-month return on equity of 2.78%. Is InfuSystem buying back stock? InfuSystem's Board of Directors initiated a stock buyback plan on Tuesday, May 19th 2026, which allows the company to buy back $20,000,000 in shares, according to EventVestor. This means that the company could buy up to 10.3% of its stock through open market purchases. Stock buyback plans are typically an indication that the company's board of directors believes its shares are undervalued. How do I buy shares of InfuSystem? Shares of INFU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of InfuSystem own? Based on aggregate information from My MarketBeat watchlists, some other companies that InfuSystem investors own include Advanced Micro Devices (AMD), Tesla (TSLA), NVIDIA (NVDA), Meta Platforms (META), Home Depot (HD), JPMorgan Chase & Co. (JPM) and Netflix (NFLX). Company Calendar Last Earnings11/07/2024Today7/02/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (1m+) 1-Year History Jul 25 Oct 25 Jan 26 Apr 26 Jul 26 INFU's financial health is in the Green zone, according to TradeSmith. INFU has been in this zone for over one month. Industry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Surgical & medical instruments Sub-IndustryMedical Equipment Current SymbolNYSE:INFU Previous SymbolNYSE:INFU CIK1337013 Webwww.infusystem.com Phone(248) 291-1210Fax800-455-4338Employees410Year Founded2005Price Target and Rating Average Price Target for InfuSystem$15.00 High Price Target$15.00 Low Price Target$15.00 Potential Upside/Downside+47.6%Consensus RatingModerate Buy Rating Score (0-4)2.67 Research Coverage3 Analysts Profitability EPS (Trailing Twelve Months)$0.38 Trailing P/E Ratio169.36 Forward P/E Ratio67.73 P/E GrowthN/ANet Income$870 thousand Net Margins1.12% Pretax Margin2.65% Return on Equity2.78% Return on Assets1.41% Debt Debt-to-Equity Ratio0.50 Current Ratio1.98 Quick Ratio1.59 Sales & Book Value Annual Sales$142.40 million Price / Sales1.44 Cash Flow$0.79 per share Price / Cash Flow12.79 Book Value$2.47 per share Price / Book4.11Miscellaneous Outstanding Shares20,182,000Free Float19,095,000Market Cap$205.05 million OptionableOptionable Beta1.40 Social Links Don't Wait for the OpenAI IPOThe AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.Get This Free Report This page (NYSE:INFU) was last updated on 7/3/2026 by MarketBeat.com Staff. From Our PartnersTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredDo NOT Buy SpaceX – Do This InsteadSpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...Stansberry Research | SponsoredSPCX Warning - and Worst News for Stocks in 50 YearsGoldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...TradeSmith | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredTrump just signed itA recent policy development is drawing attention from income-focused investors. According to one analyst, c...Investors Alley | SponsoredFrom the man who predicted 2008 crash…Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...Porter & Company | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredBetter than SpaceX? Grab this ticker instead.Larry Benedict generated $274 million for his clients by finding the trades most investors missed. Now he says...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InfuSystem Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share InfuSystem With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
